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Wüst RC, Stienen GJ. Successive contractile periods activate
mitochondria at the onset of contractions in intact rat cardiac trabec-
ulae. J Appl Physiol 124: 1003–1011, 2018. First published January
11, 2018; doi:10.1152/japplphysiol.01010.2017.—The rate of oxida-
tive phosphorylation depends on the contractile activity of the heart.
Cardiac mitochondrial oxidative phosphorylation is determined by
free ADP concentration, mitochondrial Ca2 accumulation, mito-
chondrial enzyme activities, and Krebs cycle intermediates. The
purpose of the present study was to examine the factors that limit
oxidative phosphorylation upon rapid changes in contractile activity
in cardiac muscle. We tested the hypotheses that prior contractile
performance enhances the changes in NAD(P)H and FAD concentra-
tion upon an increase in contractile activity and that this mitochondrial
“priming” depends on pyruvate dehydrogenase activity. Intact rat
cardiac trabeculae were electrically stimulated at 0.5 Hz for at least 30
min. Thereafter, two equal bouts at elevated stimulation frequency of
1, 2, or 3 Hz were applied for 3 min with 3 min of 0.5-Hz stimulation
in between. No discernible time delay was observed in the changes in
NAD(P)H and FAD fluorescence upon rapid changes in contractile
activity. The amplitudes of the rapid changes in fluorescence upon an
increase in stimulation frequency (the on-transients) were smaller than
upon a decrease in stimulation frequency (the off-transients). A first
bout in glucose-containing superfusion solution resulted, during the
second bout, in an increase in the amplitudes of the on-transients, but
the off-transients remained the same. No such priming effect was
observed after addition of 10 mM pyruvate. These results indicate that
mitochondrial priming can be observed in cardiac muscle in situ and
that pyruvate dehydrogenase activity is critically involved in the
mitochondrial adaptation to increases in contractile performance.
NEW & NOTEWORTHY Mitochondrial respiration increases with
increased cardiac contractile activity. Similar to mitochondrial “prim-
ing” in skeletal muscle, we hypothesized that cardiac mitochondrial
activity is altered upon successive bouts of contractions and depends
on pyruvate dehydrogenase activity. We found altered bioenergetics
upon repeated contractile periods, indicative of mitochondrial priming
in rat myocardium. No effect was seen when pyruvate was added to
the perfusate. As such, pyruvate dehydrogenase activity is involved in
the mitochondrial adaptation to increased contractile performance.
glucose; mitochondrial energetics; myocardium; pyruvate; repeated
contractions
INTRODUCTION
In a healthy heart, an increase in contractile activity results
in a rapid increase in the rate of oxidative phosphorylation in
the mitochondria (in situ mechanical-energetic coupling). In
isolated mitochondria, an increase in free ADP concentration
provides a feedback signal regulating mitochondrial oxidative
phosphorylation with first-order Michaelis-Menten kinetics
(e.g., Ref. 10). However, the in vivo ADP concentration does
not change significantly upon a rapid increase in cardiac
workload (3), indicating that other factors contribute to the
regulation of oxidative phosphorylation in intact cardiac mus-
cle. Indeed, in intact cell systems, oxidative phosphorylation is
governed by a higher order, allosteric mechanism (2, 27, 32,
34). The process underlying this control mechanism that has
received the most attention is the accumulation of mitochon-
drial calcium, increasing Krebs cycle enzyme activities and/or
mitochondrial complexes, effectively resulting in an increase
in the rate of mitochondrial respiration (2, 14). These processes
are influenced by the buffering capacity of phosphocreatine
(15), substrate availability (12, 26), transporter activities (22),
and the dependency of Krebs cycle enzyme activities on the
concentration of intermediates and cofactors (36).
The consequence of these activity-related alterations is that
cardiac mitochondrial bioenergetics are likely time dependent,
similar to skeletal muscle (24, 35). In skeletal muscle, this prior
exercise effect, generally referred to as “priming” (see Ref.
24), has been proposed to be the result of increased microvas-
cular O2 delivery (19, 23) and/or the increase in pyruvate
dehydrogenase (PDH) activity upon an increase in repeated
contractions (alleviating the intramuscular “inertia”) (16, 17,
20, 29). More recently, studies using isolated skeletal muscle
fibers suggest that the activation of the mitochondrial com-
plexes shows a time delay at onset of contractions (35) and that
oxidation of NADH is faster following prior contractions (13).
We previously demonstrated that cardiac trabeculae do not
show a time delay in changes in NAD(P)H and FAD fluores-
cence upon an increase in contractile output, indicative of an
effective coupling between contractile and energetic function
(34). Whether cardiac muscle shows any alterations in contrac-
tile and mitochondrial function after a prior bout of increased
contractile activity is, however, unknown.
Here, we adopted a photometry-based technique to simulta-
neously measure contractile properties and NAD(P)H and FAD
fluorescence in intact rat cardiac trabeculae (4–8, 30, 31, 34).
NAD(P)H and FAD fluorescence showed mirror-like respo-
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nses upon a rapid change in stimulation frequency (34). The
NAD(P)H and FAD responses upon an increase in stimulation
frequency consist of an early rapid response, which coincides
with the increase in contractile output (21). The rapid drop in
NAD(P)H fluorescence is indicative of net NADH oxidation
through mitochondrial complex I. Similarly, the rapid rise in
FAD fluorescence reflects net FADH2 oxidation through mi-
tochondrial complex II.
To study time-dependent aspects of contractile and mito-
chondrial function, we applied two repeated bouts of increased
stimulation frequency (1, 2, and 3 Hz) while the stimulation
frequency was 0.5 Hz before and in between bouts. We tested
the hypothesis that previous increased contractile activity en-
hances the changes in NAD(P)H and FAD fluorescence (prim-
ing). Since PDH activity is known to be higher at the start of
the primed contractions (17) and can alleviate the metabolic
inertia related to activation of the Krebs cycle enzymes, we
added pyruvate to glucose-superperfused rat trabeculae to ac-
tivate PDH. We hypothesized that this would alter NAD(P)H
and FAD kinetics and mitigate the metabolic effects of suc-
cessive contractions in cardiac muscle, as suggested from
31P-NMR studies (12).
MATERIALS AND METHODS
Animals and Ethical Approval
All protocols were in accordance with the guidelines of the Animal
Experimental Welfare Committee of the VU University Medical
Centre (Amsterdam, The Netherlands), where all experiments were
performed.
Experimental Conditions
The isolation procedure of the cardiac trabeculae was as described
previously (31, 34). In short, male Wistar rats (~300 g, n  10) were
anaesthetized by isoflurane inhalation. The heart was rapidly removed
and retrogradely (Langendorff) perfused with a modified Krebs-
Henseleit (Tyrode) solution, consisting of the following (in mM): 118
NaCl, 4.5 KCl, 0.5 CaCl2, 0.33 NaH2PO4, 1 MgCl2, 25 NaHCO3, and
10 glucose, gassed with 95% O2-5% CO2 at pH 7.45, and supple-
mented with 20 mM 2,3-butanedione monoxime to inhibit crossbridge
cycling. A thin trabecula (diameter: 200 m) from the right ventri-
cle was dissected and mounted in an experimental chamber between
a force transducer and a micromanipulator. The trabecula was con-
stantly superfused with oxygenated Tyrode solution (without 2,3-
butanedione monoxime) to guarantee adequate oxygen supply. For the
pyruvate superfusion (n  6), the glucose containing Tyrode solution
was supplemented with 10 mM sodium pyruvate. We refer to this
latter solution as pyruvate and to the solution with only glucose as
glucose. The optimal length of the preparation was determined while
the trabecula was stimulated at 0.5 Hz, and the preparation was
stretched until developed tension was maximal. On the basis of a
recent study, we estimate that sarcomere length at rest was 2.1 m (9).
At optimal length, the diameters were measured in two perpendicular
directions and the cross-sectional area was calculated assuming an
elliptical cross section. Temperature was kept at 27°C to maintain
stability of the preparation during the experiments.
Experimental Setup
A detailed description of the setup is given in Wüst et al. (34). In
short, the trabecula was supramaximally stimulated and the central
part of the trabecula was illuminated at 340 nm to asses NAD(P)H
fluorescence, immediately followed by illumination at 480 nm for
FAD fluorescence. Emitted light with a wavelength of 455 nm was
guided to a photomultiplier tube (H7360–02MOD; Hamamatsu, Ja-
pan) for detection of NAD(P)H fluorescence. FAD fluorescence at 520
nm was detected with a second photomultiplier tube. To minimize
movement artifacts and bleaching, fluorescence of NAD(P)H and
FAD was examined for a period of 10 ms each at 1-s intervals, during
the final diastolic phase of the contraction. Previously, we showed that
NAD(P)H in similar trabeculae was 63  10% reduced at 0.5 Hz, and
FAD was 57  19% oxidized at 0.5 Hz (34). In cardiac tissue, the
NAD(P)H fluorescence signal primarily arises from the mitochondrial
pool of NADH (11) and the contribution of NADPH is negligible (25).
Experimental Protocol
The experimental protocol was started with experiments (n  10
trabeculae) in glucose by recording force and NAD(P)H and FAD
fluorescence signals at a stimulation frequency of 0.5 Hz for 3 min.
Thereafter, the trabecula was stimulated at a higher stimulation
frequency of 1, 2, and 3 Hz for at least 3 min to study the tension-
frequency relationship.
Mitochondrial priming was studied after a recovery period of at
least 30 min at 0.5-Hz stimulation. This was followed by a first bout
of 3 min at a stimulation frequency of 1, 2, or 3 Hz, followed by a
recovery period at 0.5 Hz of 3 min. Thereafter, a second bout with the
same stimulation frequency as the first bout was applied. An equili-
bration period at 0.5-Hz stimulation of at least 30 min was applied
between successive runs, and stimulation sequences at 1, 2, and 3 Hz
were selected at random. In six trabeculae, this protocol was repeated
after the addition of pyruvate (10 mM) to the superfusate while the
trabecula was stimulated at 0.5 Hz and when a new steady state in
maximal force production was attained (45 min). This sequence
(first glucose and then pyruvate) was used because the time to reach
a steady state in tension development was much larger when the
measurements in pyruvate-containing solution preceded those in glu-
cose.
Calculations
Maximal (peak) tension, i.e., peak force divided by the cross-
sectional area of the preparation (Tpeak, in mN/mm2), was determined
for each contraction during the experimental runs. The steady-state
Tpeak reached was used to construct the tension-frequency relation-
ship. The steady-state values for the maximal rate of contraction
(MRC, in s1) and relaxation (MRR, in s1) normalized for Tpeak
were determined at each stimulation frequency and experimental
condition. The tension-time-integral per second (TTI/s, in mN/mm2)
was determined throughout the experimental run and is equal to the
averaged developed tension. It is a good indicator of total mechanical
output and the associated energy utilization.
The changes in NAD(P)H and FAD fluorescence reflect net changes in
concentration. As such, a decrease in NAD(P)H fluorescence indicates
that NADH utilization by complex I is larger than NADH supply by the
Krebs cycle, whereas the opposite holds for the changes in FAD (through
complex II). Background values for NAD(P)H and FAD fluorescence
were subtracted, and all values during each experimental run were
normalized to the initial value (100%). A very marginal rundown of
NAD(P)H and FAD fluorescence over the experimental run of ~15
min was accounted for by correcting the slope of the decline in
fluorescence.
The kinetics of the slow changes in NAD(P)H and FAD fluores-
cence in pyruvate- containing solutions were fitted using a single
exponential equation in Prism 5 (GraphPad Software, La Jolla, CA).
Statistical Analysis
Comparisons were made using ANOVA repeated-measures (with
substrate, bout, and/or stimulation frequency as within factors,
followed by Bonferroni post hoc tests) or paired t-tests where
appropriate. The level of significance was set at P  0.05. Statis-
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tical analyses were performed using SPSS 20.0 (IBM SPSS Sta-
tistics, Armonk, NY) or Prism 7 (GraphPad Software). All data are
presented as means  SD.
RESULTS
Contractile Properties and NAD(H) and FAD Fluorescence
Changes in Pyruvate
Figure 1 shows typical examples of the effect of a prior bout
of increased contractile activity on TTI/s, NAD(P)H, and FAD
fluorescence during an experimental run, in which stimulation
frequency was increased to 3 Hz in glucose. No time delays in
the abrupt changes in NAD(P)H and FAD fluorescence were
observed upon the changes in TTI/s.
Contractile Properties
The frequency-dependent steady-state contractile properties
in the second bout were not significantly different from the first
bout (Table 1). These results indicate that contractile activity is
not influenced by a prior bout of high stimulation and that the
difference in contraction-related energy utilization between
subsequent bouts, if any, would be very small.
NAD(P)H and FAD Responses
Early fast responses. In glucose, the time to reach the initial
minima (and maxima) in NAD(P)H and FAD responses was
similar in NADH(P)H and FAD, and the values were averaged.
Time to reach minima and time to reach maxima were larger
for 1 Hz (9.6  3.8 s) compared with 2 and 3 Hz (6.3  2.0
and 6.6  1.8 s, respectively; P  0.004) and were also longer
for the on-transient (8.3  2.8 s) compared with the off-
transient (5.9  2.3 s; P  0.003). No differences in time
course were observed between the first and second bout (P 
0.97) nor between NAD(P)H and FAD fluorescence (P 
0.99). These results suggest that the time to reach the initial
minima (and maxima) was reached faster at higher stimulation
frequencies but was not influenced by prior contractions.
Amplitudes of the early rapid changes. The amplitudes of
the early rapid changes in NAD(P)H fluorescence were linearly
related to the changes in average tension (	TTI/s), both during
the on- and off-transients (Fig. 2, A and B). In glucose, the
initial decline in NAD(P)H during the second bout was larger
than during the first bout (P  0.001; Fig. 2A), and the
difference increased with stimulation frequency (interaction
effect: P  0.001). This effect was not explained by the





































Fig. 1. Representative example of an experimental run in glucose. A: tension-
time-integral per second (TTI/s). B: NAD(P)H fluorescence. C: FAD fluores-
cence in glucose. The first 3 min at increased stimulation frequency (here 3 Hz)
were recorded after a period of at least 30 min of stimulation at 0.5 Hz (first
bout in gray lines). This was followed by a 3-min stimulation at 0.5 Hz and
a subsequent bout at a 3-Hz stimulation for 3 min (second bout in black
lines). Note that the changes in NAD(P)H (B) are opposite to those in
FAD (C).
Table 1. Contractile properties of rat cardiac trabeculae in
glucose- and pyruvate-containing superfusion solution in the
first and second bout
Glucose Pyruvate
First bout Second bout First bout Second bout
Tpeak, mN/mm2
0.5 Hz 21.4  5.9 21.3  6.4 35.1  12.8* 33.5  13.1*
1 Hz 21.5  6.2 23.2  4.0 33.8  13.1* 35.5  14.0*
2 Hz 26.7  9.3# 27.7  8.7# 38.9  12.8* 41.4  13.2*#
3 Hz 30.0  9.2# 30.3  8.2# 43.0  11.0*# 47.5  9.5*#
TTI/s
0.5 Hz 1.6  1.0 1.6  0.9 3.8  2.6* 3.7  2.7*
1 Hz 3.0  1.7# 3.0  1.8# 6.8  4.6*# 7.1  4.7*#
2 Hz 5.7  2.6# 5.9  2.6# 13.7  5.7*# 14.4  5.8*#
3 Hz 9.9  4.1# 10.8  4.2# 19.9  8.8,# 20.1  9.2*#
MRC
0.5 Hz 12.5  0.5 12.9  0.7 9.1  1.1* 9.7  1.3*
1 Hz 13.8  0.6# 13.9  0.7 10.4  2.0* 10.1  1.8*
2 Hz 14.9  0.5# 15.2  0.3# 12.1  1.3*# 12.0  1.2*#
3 Hz 16.7  0.8# 16.7  1.1# 12.9  1.0*# 13.0  1.1*#
MRR
0.5 Hz 7.0  2.7 8.3  1.0 6.3  0.8* 6.9  0.6*
1 Hz 8.3  1.2# 8.3  1.2 6.8  0.8* 6.8  0.9*
2 Hz 9.3  1.6# 9.5  1.8# 7.9  1.3*# 8.1  1.2*#
3 Hz 10.7  2.3# 10.7  2.3# 9.3  2.1*# 9.8  2.1#
Values are means  SD. Tpeak, maximal tension (mN/mm2); TTI/s, tension
time integral per second (mN/mm2), which is equal to average tension; MRC,
maximal rate of contraction, normalized for Tpeak (s1); MRR, maximal rate of
relaxation, normalized for Tpeak (s1). *P  0.05, between substrates. #P 
0.05, compared with 0.5 Hz (ANOVA, followed by a Bonferroni post hoc test).
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slope between 	TTI/s and NAD(P)H amplitude was different
between the first and second bout: 0.59  0.22 vs. 0.80 
0.29%·mm2·mN1, respectively (P  0.008; Fig. 2A). No
differences in NAD(P)H during the off-transient were observed
between the first and second bout (P  0.599; Fig. 2B). This
suggests that the effects on mitochondrial activation are fully
developed during the first bout at elevated stimulation fre-
quency and are maintained during the second bout. Similar
effects were observed in the averaged slope of the relation
between FAD amplitude and 	TTI/s in glucose during the
on-transient (1.17  0.62 and 1.65  0.76%·mm2·mN1 for
first vs. second bout, respectively; P  0.001; Fig. 2C), whereas
also in this case the slopes of the off-transient during the first and
second bout were not different (P  0.894; Fig. 2D).
Taken together, these results indicate that the fast NAD(P)H
and FAD kinetics in glucose are modified by prior bouts at
elevated stimulation frequency. Importantly, the amplitude of
the second bout was larger, indicative of large NAD(P)H and
FADH2 utilization rates in the electron transport system, com-
pared with NAD(P)H and FADH2 production rates in the
Krebs cycle.
Slow recovery toward steady-state during high workload.
While Tpeak (and TTI/s) reached a new steady state after ~20 s,
NAD(P)H and FAD fluorescence did not stabilize until ~90 s
(at 3 Hz) or ~160 s (at 1 Hz). Compared with the initial values
before the increase in the rate of stimulation, the final values at
3 Hz in glucose for NAD(P)H tended to be lower (95  6%;
P  0.09) and were higher for FAD (110  10%; P  0.02).
No differences were observed in the final values between the
first and second bout (P  0.49). In glucose, the slow recovery
phase was not very pronounced and showed a variable time
course, which precluded characterization.
Contractile Properties and NAD(H) and FAD Fluorescence
Changes in Pyruvate
Contractile properties. Tpeak at 0.5 Hz was on average 53 
22% larger in pyruvate than in glucose (P  0.008; Table 1;
Fig. 3A). MRC and MRR were significant lower in pyruvate.
These contractile differences were maintained at higher stim-
ulation frequencies. The tension-frequency relationships were
positive both in glucose and in pyruvate (P  0.001; Fig. 3B).
These contractile alterations resulted in an approximately two-
fold increase in the steady-state TTI/s in pyruvate compared
with glucose (P  0.034; Fig. 3C). TTI/s increased linearly






















































Fig. 2. Effects of a prior contractile period on
the amplitude of the early changes in NAD(P)H
and FAD fluorescence in glucose. NAD(P)H
amplitude plotted as a function of in the change
in the tension time integral per second (	TTI/s)
for the on-transient (A) and off-transient (B) in
the first and second bouts at 1, 2, and 3 Hz in
glucose (n  10). Corresponding FAD data for
the on-transient (C) and off-transient (D). In
glucose, prior contractions resulted in larger
NAD(P)H and FAD amplitudes in the on-
transient (A and C) but not in the off-tran-
sients (B and D). The on-off asymmetry in
NAD(P)H and FAD amplitude was also re-
flected in differences in the slope. Results are
shown as means  SE. *P  0.05, between
first and second bout (ANOVA, followed by a
Bonferroni post hoc test).
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was larger in pyruvate compared with glucose (interaction
effect: P  0.002; Fig. 3C). No differences in Tpeak, TTI/s,
MRC, and MRR between the first and second bout were
observed in pyruvate (Table 1).
Early fast responses. Figure 4 shows typical examples of the
effect of a prior bout of increased contractile activity on TTI/s,
NAD(P)H, and FAD fluorescence during an experimental run
in pyruvate, in which stimulation frequency was increased to
3 Hz.
As was the case in glucose, no time delays in the abrupt
changes in NAD(P)H and FAD fluorescence were observed
upon the changes in TTI/s. In pyruvate-containing solution,
the time to reach the initial minima (and maxima) in
NAD(P)H and FAD responses was not different between the
first and second bout, and the data were pooled [8.9  3.7
and 9.3  1.3 s for NAD(P)H and FAD, respectively]. Time
to reach minima and time to reach maxima were larger for
1 Hz (9.8  1.8 s) compared with 2 and 3 Hz (6.3  1.6 and
6.6  0.9 s, respectively; P  0.001) and were longer for
the on-transient (10.4  2.3 s) compared with the off-





































Fig. 4. Representative example of an experimental run in pyruvate. A: tension-
time-integral per second (TTI/s). B: NAD(P)H fluorescence. C: FAD fluores-
cence in pyruvate. The first 3 min at increased stimulation frequency (here 3
Hz) were recorded after a period of at least 30-min stimulation at 0.5 Hz (first
bout in gray lines). This was followed by a 3-min stimulation at 0.5 Hz and a
subsequent bout at 3-Hz stimulation for 3 min (second bout in black lines). The
dotted lines represent the fitted exponential curves. Note that the changes in
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Fig. 3. Force-frequency relationship in glucose and pyruvate containing solu-
tions. A: steady- state tension response in glucose and pyruvate containing
solution at a stimulation frequency of 0.5 Hz. Both amplitude and duration of
the tension transients in pyruvate were larger than in glucose. B: a positive
tension-frequency relationship was observed in glucose as well as in pyruvate.
C: the tension-time-integral per second (TTI/s) was linearly related to stimu-
lation frequency in both glucose and pyruvate, but the slopes were different.
Data are means  SE (n  6). *P  0.05, between substrates (ANOVA,
followed by a Bonferroni post hoc test).
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tension (	TTI/s) were larger in pyruvate than in glucose, but
the NAD(P)H amplitude increased in proportion with
	TTI/s (Fig. 5). The averaged data showed an excellent
correlation between NAD(P)H amplitude and 	TTI/s during
the on-transient (R2  0.887; P  0.001; slope: 0.77 
0.11%·mm2·mN1) and off-transient (R2  0.864; P 
0.001; slope: 1.37  0.20%·mm2·mN1), albeit with marked
and highly significant differences (P  0.001) in steepness.
The slopes of the relation between FAD amplitude and
	TTI/s in glucose and pyruvate were similar during the on-
transient (P  0.403; slope: 1.00  0.0.38%·mm2·mN1), but
during the off-transient the slope in pyruvate was less than half of
the slope in glucose (P  0.001; 1.84  0.69 vs. 0.59 
0.33%·mm2·mN1 for glucose and pyruvate, respectively).
The differences in NAD(P)H amplitudes between glucose and
pyruvate at the same stimulation frequency can therefore be
attributed to quantitative differences in contractile output.
Importantly, the difference in NAD(P)H and FAD amplitude
between the first and second bout was absent in pyruvate (P 
0.834; Fig. 5). Similarly, the slopes of the relation between
NAD(P)H and FAD amplitudes and 	TTI/s were not altered
(P  0.200 and 0.623 for NAD(P)H and FAD, respectively).
The FAD amplitudes in the second bout even tended to become
smaller than in the first bout (P  0.065). Taken together, these
results indicate that the fast NAD(P)H and FAD kinetics are
modified by prior bouts at elevated stimulation frequency in
glucose but not in pyruvate.
Slow recovery toward steady-state during high workload. In
pyruvate, recovery of NAD(P)H and FAD fluorescence took
place in a monoexponential fashion (Fig. 6). The rate constants
governing the slow recovery in NAD(P)H and FAD fluores-
cence in pyruvate were not different between the first and
second bout of contractions during the on-transient (P  0.267
and 0.924, respectively) or the off-transient (P  0.399 and
0.274, respectively). This indicates that prior activity does
not significantly modulate the slow adjustment in NAD(P)H
and FAD kinetics in pyruvate, and therefore, the rate con-
stants obtained during the first and second bouts were
pooled. The (pooled) rate constants of the slow recovery
during the on-transient (kon) increased significantly with
stimulation frequency [P  0.019 and 0.018 for NAD(P)H
and FAD, respectively; Fig. 6] but not during the off-
transient (koff; P  0.182 and 0.274, respectively). The
value of kon at 3 Hz was significantly higher than koff (P 
0.05; Fig. 6). These data indicate a more rapid adjustment of
NAD(P)H and FADH2 production to utilization at high

















































Fig. 5. Effects of a prior contractile period on
the amplitude of the early changes in NA-
D(P)H and FAD fluorescence in pyruvate.
NAD(P)H amplitude plotted as a function of
the change in the tension time integral per
second (	TTI/s) for the on-transient (A) and
off-transient (B) in the first and second bouts
at 1, 2, and 3 Hz (n  6). Corresponding
FAD data for the on-transient (C) and off-
transient (D). The on-off asymmetry in NA-
D(P)H and FAD amplitude is reflected in a
difference in slope (note the differences in
scale). Results are shown as means  SE.
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The final values reached at 3 Hz were larger than initial
values for NAD(P)H (106.1  3.7%; P  0.021) but not for
FAD (98.7  7.2%; P  0.480).
DISCUSSION
In this study, NAD(P)H and FAD kinetics were measured
simultaneously, on a second-to-second basis in intact cardiac
trabeculae, to study the processes underlying the early fast as
well as the later slow responses to increased contractile activ-
ity. We observed that 1) a first bout in glucose-containing
superfusion solution resulted, during the second bout, in an
increase in the amplitudes of the on-transients, but the off-
transients remained the same; and 2) this priming effect of the
on-transient was absent after addition of pyruvate (10 mM) to
the superfusate.
Successive Contractile Periods
Mitochondrial activity was markedly altered by a prior bout
of elevated stimulation frequency but interestingly only in
glucose-perfused trabeculae. In glucose, the early rapid in-
creases in NAD(P)H and FAD fluorescence upon the second
(primed) bout were considerably larger than those during the
first (unprimed) period of increased stimulation. The rapid
changes and the subsequent slow recovery in NADH and FAD
originate, as discussed previously (see Fig. 7 in Ref. 34), from
a dysbalance of the velocity of NADH/FADH2 supply and
demand. These differences could either be explained by an
increase in the rate of NADH and FADH2 oxidation, i.e.,
complex I and II activity, or by a blunted rise in the rate of
NAD and FAD reduction in the Krebs cycle. The latter
possibility, however, seems unlikely because Krebs cycle en-
zyme activity is expected to be higher, rather than lower in the
primed condition (12, 17). Rather, mitochondrial complexes
(not only complex I and II, but also others) are activated to a
net larger extent upon an increase in stimulation frequency and
subsequent mitochondrial calcium concentration (14, 33) and
remained activated during the off-transient and subsequent
bouts. Indeed, in skeletal muscle fibers, mitochondrial enzyme
deactivation at the off-transient is suggested to be slower than
the rapid mitochondrial activation at the onset of contractions
(13, 35). Here, mitochondrial enzyme activity remained ele-
vated for at least 3 min.
There was no delay in the change in NAD(P)H and FAD
fluorescence upon a change in contractile activity, and NAD(P)H
and FAD fluorescence slowly recovered toward baseline values
throughout the stimulation period. This was different compared
with changes in NAD(P)H fluorescence in skeletal muscle
(13). In a second, successive, bout of contractions in skeletal
muscle, a faster NADH utilization rate and a delayed and less
pronounced decrease in mitochondrial membrane potential
upon an increase in stimulation frequency (13) suggest that in
primed skeletal muscle mitochondria the redox potential [i.e.,
NAD(P)H/NAD(P)] and the proton motive force (13) are more
in equilibrium. Here, we also observed larger NADH and
FADH2 utilization rates at the start of the primed bout, imply-
ing that mitochondrial complex activity was higher in the
second compared with the first bout. Whether this would also
result in alterations in mitochondrial membrane potential,
faster oxygen consumption rates (at complex IV), and/or ATP
phosphorylation rates (at complex V) is not known.
The observation that mitochondrial priming was only seen in
glucose and not in pyruvate can be attributed to a higher PDH
activity in pyruvate (26, 36). It is well established that the
maximal PDH capacity is not fully exploited at high cardiac
output in glucose (26). This is in contrast to the situation in
pyruvate where PDH activity was higher at low and high
cardiac output (26). Surprisingly, however, the NAD(P)H and
FAD amplitudes were larger, rather than smaller in pyruvate,
despite the higher production rates in the Krebs cycle. These
results suggest that pyruvate is able to relieve the metabolic
inertia (16), such that complex I and II activity adapt more
rapidly at the start of the bout. Higher PDH activity also
directly increases mitochondrial complex I activity through
deactivation of PDH kinase (28).
Another possibly contributing factor could be a shift in the
relative contributions of the oxidative and nonoxidative me-
tabolism at the first and the second train of contractions by
changes in phosphocreatine kinetics. However, the free ADP
concentration does not change over a range of rate-pressure
products in cardiac muscle (3). Indeed, a recent overview of the
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Fig. 6. Rate constants of slow recovery phases at different stimulation fre-
quencies. A: rate of NAD(P)H recovery during the on- and off-transients in
pyruvate. B: rate of FAD recovery during the on- and off-transients. Values of
the first and second bout were averaged, because no differences were observed.
Results are shown as means  SE (n  6). *P  0.05, compared with 1 Hz.
#P  0.05, compared with off-transient (ANOVA, followed by a Bonferroni
post hoc test (P  0.05).
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creatine/ATP with increased heart rate. Therefore, we expect
that this contribution, if present, would be small.
Substrate Dependency: Glucose vs. Pyruvate
In agreement with previous studies (18, 36), we observed a
larger amplitude and duration of the contractile responses in
pyruvate compared with glucose, which resulted in an approx-
imately twofold larger TTI/s at the same stimulation frequency.
This increase in contractile output is most likely attributable to
cytosolic factors, such as changes in calcium handling, intra-
cellular pH, inorganic phosphate concentration, and 	GATP
(36). The alterations in Ca2 handling result in an increase in
Ca2 loading of the sarcoplasmic reticulum, which causes an
increased Ca2 release during contraction, while a decline in
inorganic phosphate concentration and an increase in cytosolic
pH both result in an increased Ca2 sensitivity of the myofila-
ments (18). In concert, these factor contribute to an increase
and prolongation of force production. These changes might be
of therapeutic relevance (18), but the linear relationship be-
tween NAD(P)H and FAD amplitude and 	TTI/s was pre-
served. Our study thus illustrates that the higher contractile
output in pyruvate is accompanied by a larger energy demand,
which requires an adequate mitochondrial adaptation (31).
Further studies are warranted to assess potential energetic
benefits of pyruvate.
Previous studies in cardiac trabeculae focused on NAD(P)H
kinetics using pyruvate-perfusion only (5–8). Despite that
pyruvate increased Krebs cycle enzyme activities (and
speeded up NADH and FADH2 utilization upon an increase
in contractile activity), on-off asymmetry also occurred in
pyruvate-containing medium. This asymmetry is consistent
with a parallel activation of the NADH-producing and
-utilizing pathways, both in glucose and in pyruvate, when
energy requirements are increased. An increase in Krebs
cycle enzyme and mitochondrial activities throughout the bout
of increased ATP utilization likely underlies the on-off-asym-
metry in NAD(P)H and FAD kinetics in glucose and pyruvate.
Fast uptake and slow restitution of mitochondrial calcium upon
changes in stimulation frequency (33) and its effect on NADH-
and FADH2-utilizing pathways could be responsible for this
phenomenon.
It can be noted that the final values of the slow recovery
phase at 3 Hz were larger than initial values for NAD(P)H, but
not for FAD. We attribute this latter finding to the relatively
large variability in FAD fluorescence in the recordings. The
rapid drop in FAD concentration upon a decrease in stimula-
tion frequency (the off-transient, Fig. 5D) in pyruvate was
smaller than expected from the measurements in glucose. This
suggests that succinate dehydrogenase (mitochondrial complex
II) kinetics are altered upon the addition of pyruvate.
Conclusion
Our experiments show that a prior bout of elevated contrac-
tile activity influences mitochondrial bioenergetics and there-
fore provides evidence for priming of mitochondrial activity in
cardiac muscle tissue. Our results also indicate that PDH
activity is critically involved in the process of mitochondrial
adaptation to increases in contractile performance in cardiac
tissue.
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